Anzeige
Mehr »
Login
Samstag, 04.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Schnelle Produktionsaufnahme: Multi-Tenbagger-Potenzial direkt in Spanien?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Business Wire-Archiv vom 10.09.2023

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
10.09.23Celltrion Healthcare: Celltrion Celebrates a Decade of Biosimilar Innovation in Europe617Today marks 10 years since the European Medicines Agency (EMA) approved the world's first monoclonal antibody biosimilar infliximab, for all indications of the reference product. The previous...
► Artikel lesen
10.09.23Daiichi Sankyo: Datopotamab Deruxtecan Plus Durvalumab Showed Promising Clinical Activity in the First-Line Advanced Non-Small Cell Lung Cancer Setting in TROPION-Lung04 Phase 1b Trial776Daiichi Sankyo and AstraZeneca's datopotamab deruxtecan plus durvalumabwith or without chemotherapy demonstrated objective response rates of 77% and 50% and disease control rates of 92% and 93%...
► Artikel lesen
10.09.23Earnix Appoints Erez Barak as Chief Technology Officer420Will Advance Technological Innovation and Analytics Capabilities Earnix, the global provider of intelligent SaaS solutions for insurers and banks, today announced the appointment of Erez Barak...
► Artikel lesen
10.09.23Bristol Myers Squibb's Investigational LPA1 Antagonist Reduces Rate of Lung Function Decline in Progressive Pulmonary Fibrosis Cohort of Phase 2 Study781Results show 26 weeks of treatment with twice-daily 60 mg dose of BMS-986278 resulted in a 69% relative reduction in the rate of decline in percent predicted forced vital capacity versus placebo...
► Artikel lesen